BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 1, 2016
View Archived Issues
European orphan drug designation for fimaporfin to treat cholangiocarcinoma
Read More
Good Doctor Pharmaceutical Group reports new PDE inhibitors
Read More
Oncocure Biotechnology patents CRM1 inhibitors
Read More
Glenmark Pharmaceuticals discloses ADH5 inhibitors
Read More
Constellation Pharmaceuticals describes EZH2 inhibitors
Read More
PsychoGenics and Sunovion Pharmaceuticals develop antidepressants
Read More
Daewoong Pharmaceutical announces Nav1.7 sodium channel blockers
Read More
Latanoprost-eluting contact lenses demonstrate IOP-lowering effects in vivo
Read More
Betagenon and Baltic Bio start phase IIa trial of O-304
Read More
Kleo licenses IP rights from Yale, completes Series A funding
Read More
Scientists identify novel disease-causing mutations in DSP gene
Read More
European Commission approves Pfizer's crizotinib for ROS-1 positive NSCLC
Read More
Novartis presents new tetrahydroisoquinoline with good oral bioavailability in vivo
Read More
Mallinckrodt completes Stratatech acquisition
Read More
Forma Therapeutics meets development milestone in collaboration with Celgene
Read More
Aptahem reports on anticoagulant effect of APTA-1 in animal studies
Read More
Facio establishes tool to aid in FSHD drug discovery
Read More
AbbVie reports development of selective BET family bromodomain inhibitors
Read More
Neurocrine submits NDA for valbenazine in the treatment of tardive dyskinesia
Read More
SK Chemicals launches SKYCellflu Quadrivalent influenza vaccine in South Korea
Read More
MK-8449: a second generation SYK/ZAP70 inhibitor from Merck
Read More
FDA awards Santhera USD 246,000 for the development of omigapil
Read More
Intramyocardial AdVEGF-DdNdC gene therapy shows potential in patients with refractory angina
Read More
Santen and Kerui establish ophthalmic joint venture in China
Read More
NIAID grant supports Sedia's development of HIV test for recent infections
Read More
Expected efficacy not observed in Japanese phase II/III study of HP-3150 for cancer pain
Read More
FDA grants orphan drug designation to nivolumab for the treatment of esophageal cancer
Read More